Maria Zannes - 08 Apr 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role: President & CEO
Signature: /s/ Maria Zannes
Issuer symbol: BIAF
Transactions as of: 08 Apr 2024
Net transactions value: +$324
Form type: 4
Filing time: 24 Apr 2024, 16:00:25 UTC
Previous filing: 02 Feb 2024
Next filing: 14 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIAF	Common Stock	Options Exercise	$75,224	+64,848	+39%	$1.16	229,506	08 Apr 2024	Direct
transaction	BIAF	Common Stock	Tax liability	$74,900	-28,264	-12%	$2.65	201,242	08 Apr 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIAF	Stock Option (right to buy)	Options Exercise	$0	-64,848	-100%	$0.000000^*	0	08 Apr 2024	Common Stock	64,848	$1.16	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld to cover the exercise price of the options exercised.
F2	This option vested in 7 equal monthly installments beginning on April 28, 2014.